美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Polyrizon Ltd.

10.30

-0.1900-1.81%

盤後：10.00-0.3000-2.91%16:30 EDT

成交量：2.32萬

成交額：24.11萬

市值：2,146.50萬

市盈率：-2.10

高：10.86

開：10.86

低：10.25

收：10.49

52周最高：18.20

52周最低：2.88

股本：208.40萬

流通股本：164.89萬

量比：0.20

換手率：1.41%

股息：- -

股息率：- -

每股收益(TTM):-4.9017

淨資產收益率：-25.38%

總資產收益率：-28.95%

市淨率：1.02

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

Polyrizon完成Nasarix™研究臨床中心網絡建設，向患者入組邁進

Polyrizon公布Nasarix™生物相容性項目成功結果，支持向首次人體臨床試驗邁進

Polyrizon Ltd. 取得重大進展：其過敏阻斷劑臨床試驗獲中央機構審查委員會批准

Polyrizon 獲歐洲專利局發布通知，其創新型黏膜黏附鼻腔給藥技術獲專利公開

Polyrizon與Arrow Aviation簽署函件協議將MOU下的排他期及初期談判期延長至6月30日

Polyrizon Ltd.為其藥物遞送平台提交歐洲專利申請

Polyrizon Ltd. 簽署協議進行普通股及預融資認股權證的註冊直接發行

Polyrizon計劃收購先進eVTOL無人機開發商Colugo至多20%股權

Polyrizon攜手全球領先臨床前CRO，加速推進臨床開發項目

Polyrizon Ltd.盤中異動大幅下挫5.17%

Polyrizon宣佈與Eurofins CDMO Amatsiaquitaine S.a.s合作生產cGMP臨床實驗材料，用於計劃中的美國臨床研究

Polyrizon宣佈其納洛酮製劑研究取得積極成果，鼻腔沉積特性優於市售參照產品

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/PLRZ/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PLRZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLRZ\",,,,,undefined,":{"symbol":"PLRZ","market":"US","secType":"STK","nameCN":"Polyrizon Ltd.","latestPrice":10.3,"timestamp":1787342400000,"preClose":10.49,"halted":0,"volume":23198,"hourTrading":{"tag":"盘后","latestPrice":10,"preClose":10.3,"latestTime":"16:30 EDT","volume":2024,"amount":20442.55,"timestamp":1787344206189,"change":-0.3,"changeRate":-0.029126,"amplitude":0.029126},"delay":0,"changeRate":-0.01811248808388937,"floatShares":1648899,"shares":2083979,"eps":-4.901672,"marketStatus":"休市中","change":-0.19,"latestTime":"08-21 16:00:00 EDT","open":10.86,"high":10.86,"low":10.252,"amount":241082.77921,"amplitude":0.05796,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.901672,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1730174400000,"exchange":"NASDAQ","adjPreClose":10.49,"preHourTrading":{"tag":"盘前","latestPrice":10.98,"preClose":10.49,"latestTime":"08:45 EDT","volume":10,"amount":109.80000000000001,"timestamp":1787316350024,"change":0.49,"changeRate":0.046711,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":10,"preClose":10.3,"latestTime":"16:30 EDT","volume":2024,"amount":20442.55,"timestamp":1787344206189,"change":-0.3,"changeRate":-0.029126,"amplitude":0.029126},"volumeRatio":0.19734782522234245},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLRZ\",,,,,undefined,":{"symbol":"PLRZ","floatShares":1648899,"roa":"-28.95%","roe":"-25.38%","lyrEps":0,"volumeRatio":0.19734782522234245,"shares":2083979,"dividePrice":0,"high":10.86,"amplitude":0.05796,"preClose":10.49,"low":10.252,"week52Low":2.88,"pbRate":"1.02","week52High":18.2,"institutionHeld":0,"latestPrice":10.3,"eps":-4.901672,"divideRate":0,"volume":23198,"delay":0,"ttmEps":-4.901672,"open":10.86,"prevYearClose":8.49,"prevWeekClose":10.98,"prevMonthClose":11.25,"prevQuarterClose":12.52,"fiveDayClose":10.98,"twentyDayClose":14.68,"sixtyDayClose":16.49},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PLRZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-28","symbol":"PLRZ","defaultRemindTime":1764340200000,"type":"split","dateTimestamp":1764306000000,"forFactor":6,"toFactor":1,"ratio":6},{"market":"US","date":"2025-05-27","symbol":"PLRZ","defaultRemindTime":1748352600000,"type":"split","dateTimestamp":1748318400000,"forFactor":250,"toFactor":1,"ratio":250}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PLRZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PLRZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PLRZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PLRZ","date":"2026-08-21","current":-2.101324,"percent":0.592018,"low":-29.515607,"twenty":-11.696628,"median":-6.632,"eighty":-3.047315,"high":-0.011381,"avg":-7.999682,"sd":6.110678,"marketCap":19635685},"quantilePoints":[{"date":"2024-10-31","current":-13.097935,"twenty":-22.948538,"median":-13.097935,"eighty":-12.489816,"marketCap":7858761},{"date":"2024-11-08","current":-3.903419,"twenty":-12.692522,"median":-4.690878,"eighty":-4.316449,"marketCap":3891709},{"date":"2024-11-15","current":-2.661127,"twenty":-9.219549,"median":-4.249136,"eighty":-3.530862,"marketCap":2653144},{"date":"2024-11-22","current":-2.985655,"twenty":-4.737156,"median":-3.736612,"eighty":-3.09924,"marketCap":2976698},{"date":"2024-11-29","current":-3.042447,"twenty":-4.451075,"median":-3.375089,"eighty":-3.037515,"marketCap":3033320},{"date":"2024-12-06","current":-3.212824,"twenty":-4.383762,"median":-3.342636,"eighty":-3.042447,"marketCap":3203186},{"date":"2024-12-13","current":-3.375088,"twenty":-4.191157,"median":-3.358862,"eighty":-3.047315,"marketCap":3364963},{"date":"2024-12-20","current":-7.561496,"twenty":-4.383762,"median":-3.375088,"eighty":-3.07146,"marketCap":7538812},{"date":"2024-12-27","current":-5.744141,"twenty":-5.095085,"median":-3.407542,"eighty":-3.090153,"marketCap":5726909},{"date":"2025-01-03","current":-5.938858,"twenty":-6.101122,"median":-3.569805,"eighty":-3.132991,"marketCap":5921041},{"date":"2025-01-10","current":-4.997727,"twenty":-6.159537,"median":-3.796975,"eighty":-3.146231,"marketCap":4982734},{"date":"2025-01-17","current":-6.142316,"twenty":-6.098128,"median":-3.933764,"eighty":-3.167391,"marketCap":6123889},{"date":"2025-01-24","current":-5.889893,"twenty":-6.192801,"median":-4.333277,"eighty":-3.193353,"marketCap":5872223},{"date":"2025-01-31","current":-5.553327,"twenty":-6.125488,"median":-4.527162,"eighty":-3.214122,"marketCap":5536667},{"date":"2025-02-07","current":-4.552045,"twenty":-6.087615,"median":-4.738105,"eighty":-3.227753,"marketCap":4538389},{"date":"2025-02-14","current":-4.711914,"twenty":-6.064471,"median":-4.705652,"eighty":-3.245278,"marketCap":4697778},{"date":"2025-02-21","current":-4.522596,"twenty":-6.049761,"median":-4.627772,"eighty":-3.258259,"marketCap":4509028},{"date":"2025-02-28","current":-3.707687,"twenty":-6.000655,"median":-4.535397,"eighty":-3.316674,"marketCap":3696564},{"date":"2025-03-07","current":-3.460732,"twenty":-5.929065,"median":-4.501561,"eighty":-3.241954,"marketCap":3450350},{"date":"2025-03-14","current":-1.846098,"twenty":-5.873065,"median":-4.396383,"eighty":-3.213473,"marketCap":2852222},{"date":"2025-03-21","current":-1.508371,"twenty":-5.793429,"median":-4.291207,"eighty":-3.160314,"marketCap":2330433},{"date":"2025-03-28","current":-1.353625,"twenty":-5.705978,"median":-3.977976,"eighty":-3.07146,"marketCap":2091350},{"date":"2025-04-04","current":-0.974631,"twenty":-5.536499,"median":-3.903419,"eighty":-3.030526,"marketCap":1505805},{"date":"2025-04-11","current":-0.980061,"twenty":-5.4398,"median":-3.702849,"eighty":-2.640357,"marketCap":1514194},{"date":"2025-04-17","current":-0.985491,"twenty":-5.322255,"median":-3.619184,"eighty":-1.846098,"marketCap":1522583},{"date":"2025-04-25","current":-0.947483,"twenty":-5.174691,"median":-3.5049,"eighty":-1.520317,"marketCap":1463861},{"date":"2025-05-02","current":-0.687943,"twenty":-5.159991,"median":-3.434137,"eighty":-1.353625,"marketCap":1062872},{"date":"2025-05-09","current":-2.602277,"twenty":-5.095085,"median":-3.375088,"eighty":-1.466019,"marketCap":4020518},{"date":"2025-05-16","current":-0.039201,"twenty":-5.02132,"median":-3.354145,"eighty":-1.299871,"marketCap":60566},{"date":"2025-05-23","current":-0.018499,"twenty":-5.006408,"median":-3.310183,"eighty":-1.057434,"marketCap":28581},{"date":"2025-05-30","current":-0.022023,"twenty":-4.999463,"median":-3.245278,"eighty":-1.021327,"marketCap":34025},{"date":"2025-06-06","current":-0.014912,"twenty":-4.937359,"median":-3.214447,"eighty":-0.978975,"marketCap":23039},{"date":"2025-06-13","current":-0.018851,"twenty":-4.922267,"median":-3.183486,"eighty":-0.945854,"marketCap":29125},{"date":"2025-06-20","current":-0.013358,"twenty":-4.871782,"median":-3.155299,"eighty":-0.895899,"marketCap":20638},{"date":"2025-06-27","current":-2.431375,"twenty":-4.817057,"median":-3.116926,"eighty":-0.895899,"marketCap":3756474},{"date":"2025-07-03","current":-2.428961,"twenty":-4.79003,"median":-3.054617,"eighty":-0.90676,"marketCap":3752744},{"date":"2025-07-11","current":-2.469311,"twenty":-4.75787,"median":-3.036282,"eighty":-0.929565,"marketCap":3815085},{"date":"2025-07-18","current":-3.343916,"twenty":-4.728069,"median":-3.039365,"eighty":-0.942596,"marketCap":5166350},{"date":"2025-07-25","current":-4.793774,"twenty":-4.784488,"median":-3.066787,"eighty":-0.954976,"marketCap":7406381},{"date":"2025-08-01","current":-9.134632,"twenty":-4.922267,"median":-3.137242,"eighty":-0.969039,"marketCap":14113006},{"date":"2025-08-08","current":-8.476938,"twenty":-5.004125,"median":-3.155299,"eighty":-0.973817,"marketCap":13096869},{"date":"2025-08-15","current":-8.18463,"twenty":-5.134029,"median":-3.19779,"eighty":-0.976803,"marketCap":12645253},{"date":"2025-08-22","current":-7.746168,"twenty":-5.410414,"median":-3.21607,"eighty":-0.982233,"marketCap":11967829},{"date":"2025-08-29","current":-7.600014,"twenty":-5.856236,"median":-3.245278,"eighty":-0.987228,"marketCap":11742021},{"date":"2025-09-05","current":-7.819245,"twenty":-6.049761,"median":-3.325781,"eighty":-0.992223,"marketCap":12080733},{"date":"2025-09-12","current":-7.143282,"twenty":-6.209629,"median":-3.343916,"eighty":-1.006667,"marketCap":11036370},{"date":"2025-09-19","current":-10.354516,"twenty":-6.696876,"median":-3.375088,"eighty":-1.026648,"marketCap":11742021},{"date":"2025-09-26","current":-11.070023,"twenty":-7.035762,"median":-3.443585,"eighty":-1.030557,"marketCap":12553406},{"date":"2025-10-03","current":-11.383325,"twenty":-7.364852,"median":-3.487865,"eighty":-1.042883,"marketCap":12908691},{"date":"2025-10-10","current":-13.054272,"twenty":-7.512322,"median":-3.569805,"eighty":-1.058791,"marketCap":14803545},{"date":"2025-10-17","current":-11.174457,"twenty":-7.59231,"median":-3.644879,"eighty":-1.068565,"marketCap":12671834},{"date":"2025-10-24","current":-11.278891,"twenty":-7.731553,"median":-3.707687,"eighty":-1.123948,"marketCap":12790262},{"date":"2025-10-31","current":-10.75672,"twenty":-7.950784,"median":-3.905854,"eighty":-1.280758,"marketCap":12198121},{"date":"2025-11-07","current":-9.567215,"twenty":-8.038476,"median":-3.996712,"eighty":-1.310622,"marketCap":10849222},{"date":"2025-11-14","current":-8.045608,"twenty":-8.360015,"median":-4.312242,"eighty":-1.376104,"marketCap":9123720},{"date":"2025-11-21","current":-6.109399,"twenty":-8.170015,"median":-4.417419,"eighty":-1.474489,"marketCap":6928059},{"date":"2025-11-28","current":-5.587228,"twenty":-8.111553,"median":-4.501561,"eighty":-1.508371,"marketCap":6335917},{"date":"2025-12-05","current":-25.23826,"twenty":-8.403861,"median":-4.535397,"eighty":-1.515701,"marketCap":28620187},{"date":"2025-12-12","current":-21.591766,"twenty":-8.696169,"median":-4.627772,"eighty":-1.520317,"marketCap":24485063},{"date":"2025-12-19","current":-17.597159,"twenty":-9.06593,"median":-4.711914,"eighty":-1.541633,"marketCap":19955178},{"date":"2025-12-26","current":-13.245735,"twenty":-9.27961,"median":-4.754698,"eighty":-1.546299,"marketCap":15020663},{"date":"2026-01-02","current":-14.777436,"twenty":-10.201257,"median":-4.798393,"eighty":-1.579229,"marketCap":16757612},{"date":"2026-01-09","current":-23.341039,"twenty":-10.662157,"median":-4.922267,"eighty":-1.630419,"marketCap":26468738},{"date":"2026-01-16","current":-21.842963,"twenty":-11.038692,"median":-4.999213,"eighty":-1.702674,"marketCap":24769920},{"date":"2026-01-23","current":-22.02569,"twenty":-11.165081,"median":-5.003554,"eighty":-1.780942,"marketCap":24977133},{"date":"2026-01-30","current":-18.441421,"twenty":-11.278891,"median":-5.035187,"eighty":-1.871075,"marketCap":20912571},{"date":"2026-02-06","current":-17.471559,"twenty":-11.383325,"median":-5.167341,"eighty":-1.959036,"marketCap":19812748},{"date":"2026-02-13","current":-19.664289,"twenty":-11.445985,"median":-5.322255,"eighty":-2.161828,"marketCap":22299304},{"date":"2026-02-20","current":-19.158274,"twenty":-11.780175,"median":-5.500199,"eighty":-2.356399,"marketCap":21725483},{"date":"2026-02-27","current":-19.24261,"twenty":-12.048622,"median":-5.587228,"eighty":-2.377712,"marketCap":21821120},{"date":"2026-03-06","current":-19.130163,"twenty":-12.337157,"median":-5.805751,"eighty":-2.404957,"marketCap":21693605},{"date":"2026-03-13","current":-21.491564,"twenty":-13.089202,"median":-5.977481,"eighty":-2.428961,"marketCap":24371434},{"date":"2026-03-20","current":-18.975548,"twenty":-13.87234,"median":-6.068669,"eighty":-2.429444,"marketCap":21518271},{"date":"2026-03-27","current":-6.571741,"twenty":-14.681705,"median":-6.104823,"eighty":-2.432754,"marketCap":21916757},{"date":"2026-04-02","current":-6.133576,"twenty":-14.29878,"median":-6.093857,"eighty":-2.438272,"marketCap":20455475},{"date":"2026-04-10","current":-5.228861,"twenty":-14.168236,"median":-6.058175,"eighty":-2.459999,"marketCap":17438252},{"date":"2026-04-17","current":-5.848317,"twenty":-13.976774,"median":-5.969011,"eighty":-2.460689,"marketCap":19504138},{"date":"2026-04-24","current":-7.906455,"twenty":-13.454603,"median":-6.058175,"eighty":-2.469311,"marketCap":26368026},{"date":"2026-05-01","current":-8.924253,"twenty":-13.245735,"median":-6.093519,"eighty":-2.483106,"marketCap":29762383},{"date":"2026-05-08","current":-7.936411,"twenty":-13.245735,"median":-6.109399,"eighty":-2.496901,"marketCap":26467930},{"date":"2026-05-15","current":-8.430332,"twenty":-13.097935,"median":-6.18242,"eighty":-2.517594,"marketCap":28115156},{"date":"2026-05-22","current":-7.100113,"twenty":-13.054272,"median":-6.295839,"eighty":-2.548287,"marketCap":23678877},{"date":"2026-05-29","current":-9.261017,"twenty":-12.817554,"median":-6.483666,"eighty":-2.548563,"marketCap":30885492},{"date":"2026-06-05","current":-7.184304,"twenty":-12.577356,"median":-6.653598,"eighty":-2.591548,"marketCap":23959654},{"date":"2026-06-12","current":-6.49955,"twenty":-12.378931,"median":-6.640969,"eighty":-2.628587,"marketCap":21675999},{"date":"2026-06-18","current":-7.425652,"twenty":-12.330195,"median":-6.571741,"eighty":-2.650742,"marketCap":24764549},{"date":"2026-06-26","current":-6.409746,"twenty":-12.260573,"median":-6.632,"eighty":-2.70965,"marketCap":21376504},{"date":"2026-07-02","current":-7.116951,"twenty":-12.177025,"median":-6.653598,"eighty":-2.796579,"marketCap":23735032},{"date":"2026-07-10","current":-8.059891,"twenty":-12.10238,"median":-6.750178,"eighty":-2.921331,"marketCap":26879737},{"date":"2026-07-17","current":-7.296559,"twenty":-12.01284,"median":-7.006752,"eighty":-2.995391,"marketCap":24334024},{"date":"2026-07-24","current":-8.593101,"twenty":-11.905496,"median":-7.027147,"eighty":-3.017632,"marketCap":28657992},{"date":"2026-07-31","current":-6.522001,"twenty":-11.884609,"median":-7.027147,"eighty":-3.030526,"marketCap":21750873},{"date":"2026-08-07","current":-6.449035,"twenty":-11.801062,"median":-6.876942,"eighty":-3.037515,"marketCap":21507533},{"date":"2026-08-14","current":-6.033693,"twenty":-11.780175,"median":-6.701609,"eighty":-3.042447,"marketCap":20122366},{"date":"2026-08-21","current":-5.887762,"twenty":-11.696628,"median":-6.632,"eighty":-3.047315,"marketCap":19635685}],"updateTime":1787476783562},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PLRZ\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1132297876","title":"Polyrizon完成Nasarix™研究臨床中心網絡建設，向患者入組邁進","url":"https://stock-news.laohu8.com/highlight/detail?id=1132297876","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132297876?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 21:30","pubTimestamp":1787232625,"startTime":"0","endTime":"0","summary":"Polyrizon已成功构建Nasarix™研究的临床中心网络，并正稳步推进至患者入组阶段。这一里程碑式的进展，标志着该公司在鼻腔给药技术领域的研究又向前迈出了关键一步。随着临床站点网络的全面落成，Polyrizon现已具备启动患者招募工作的充分条件，为后续试验的顺利开展奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105819292","title":"Polyrizon公布Nasarix™生物相容性項目成功結果，支持向首次人體臨床試驗邁進","url":"https://stock-news.laohu8.com/highlight/detail?id=1105819292","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105819292?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 19:37","pubTimestamp":1782992238,"startTime":"0","endTime":"0","summary":"Polyrizon公司宣布，其Nasarix™生物相容性项目已取得积极成果。这一关键进展有力地支持了该项目向首次人体临床试验阶段推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196122696","title":"Polyrizon Ltd. 取得重大進展：其過敏阻斷劑臨床試驗獲中央機構審查委員會批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1196122696","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196122696?lang=zh_tw&edition=fundamental","pubTime":"2026-06-29 20:45","pubTimestamp":1782737159,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. 在研发道路上迈出了坚实的一步。公司已成功获得中央机构审查委员会对其过敏阻断剂临床试验的批准，这标志着其核心产品向市场推进的关键障碍已被扫清。此项进展不仅为后续研究的开展铺平了道路，也显著增强了市场对该疗法未来潜力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177433530","title":"Polyrizon 獲歐洲專利局發布通知，其創新型黏膜黏附鼻腔給藥技術獲專利公開","url":"https://stock-news.laohu8.com/highlight/detail?id=1177433530","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177433530?lang=zh_tw&edition=fundamental","pubTime":"2026-06-10 19:47","pubTimestamp":1781092041,"startTime":"0","endTime":"0","summary":"Polyrizon 公司已收到欧洲专利局关于其创新型黏膜黏附鼻腔给药技术的专利发布通知。这一进展标志着该公司在鼻腔药物递送领域的技术创新获得了欧洲专利体系的正式认可，为其相关技术的商业化和知识产权保护奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174404710","title":"Polyrizon與Arrow Aviation簽署函件協議 將MOU下的排他期及初期談判期延長至6月30日","url":"https://stock-news.laohu8.com/highlight/detail?id=1174404710","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174404710?lang=zh_tw&edition=fundamental","pubTime":"2026-06-06 04:25","pubTimestamp":1780691121,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. 与 Arrow Aviation 已正式签署一份函件协议。根据该协议，双方此前在谅解备忘录（MOU）框架下约定的排他性谈判期及初期谈判阶段，将一并延长至今年6月30日。此举旨在为双方就潜在合作事宜提供更充分的协商时间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160225720","title":"Polyrizon Ltd.為其藥物遞送平台提交歐洲專利申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1160225720","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160225720?lang=zh_tw&edition=fundamental","pubTime":"2026-04-27 21:35","pubTimestamp":1777296906,"startTime":"0","endTime":"0","summary":"生物技术公司Polyrizon Ltd.宣布，已为其专有的药物递送平台技术提交了欧洲专利申请。此举标志着该公司在强化其知识产权组合、拓展全球市场布局方面迈出了关键一步。\n该专利的申请旨在保护其创新药物递送系统的核心技术，为其未来在欧洲市场的商业化奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162623204","title":"Polyrizon Ltd. 簽署協議進行普通股及預融資認股權證的註冊直接發行","url":"https://stock-news.laohu8.com/highlight/detail?id=1162623204","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162623204?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 20:02","pubTimestamp":1775563325,"startTime":"0","endTime":"0","summary":"生物技术公司Polyrizon Ltd. (PLRZ) 近日宣布，该公司已达成最终协议，将通过注册直接发行的方式，向机构投资者发售其普通股及预融资认股权证。\n此次发行旨在为公司的重要研发项目及一般营运资金需求筹集资金。根据市场惯例，此次发行的完成仍需满足特定的交割条件。\n通过这种融资方式，Polyrizon Ltd. 期望能加速其在研管线的进展，并进一步巩固其财务状况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198342122","title":"Polyrizon計劃收購先進eVTOL無人機開發商Colugo至多20%股權","url":"https://stock-news.laohu8.com/highlight/detail?id=1198342122","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198342122?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 20:48","pubTimestamp":1774356518,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. 已宣布一项战略投资计划，拟收购Colugo公司的部分股权。Colugo是一家专注于研发先进电动垂直起降（eVTOL）无人机的企业，其产品主要应用于国防及城市空中交通领域。根据计划，Polyrizon此次收购的股权比例最高可达20%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177669566","title":"Polyrizon攜手全球領先臨床前CRO，加速推進臨床開發項目","url":"https://stock-news.laohu8.com/highlight/detail?id=1177669566","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177669566?lang=zh_tw&edition=fundamental","pubTime":"2026-03-17 20:27","pubTimestamp":1773750433,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. (PLRZ) 已与一家全球顶尖的临床前合同研究组织（CRO）正式签署合作协议，此举是其整体临床开发计划中的关键一步。\n该合作旨在利用该CRO在临床前研究领域的专业能力和全球资源，以推进Polyrizon研发管线的进展。协议的签署标志着公司向临床阶段迈出了实质性的一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618807421","title":"Polyrizon Ltd.盤中異動 大幅下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618807421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618807421?lang=zh_tw&edition=fundamental","pubTime":"2026-03-12 03:40","pubTimestamp":1773258044,"startTime":"0","endTime":"0","summary":"北京时间2026年03月12日03时40分，Polyrizon Ltd.股票出现波动，股价快速下挫5.17%。截至发稿，该股报12.29美元/股，成交量7752股，换手率0.74%，振幅5.48%。Polyrizon Ltd.股票所在的生物技术行业中，整体跌幅为1.05%。Polyrizon Ltd.公司简介：Polyrizon Ltd是一家处于临床开发阶段的生物技术公司，专门开发鼻用凝胶，以提供抵御各种病毒的预防性治疗，包括某些 COVID-19 变种，这些变种也被认为比病毒的原始毒株引起更多的感染并传播得更快，流感、过敏原和其他毒素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312034044a6b8ccb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312034044a6b8ccb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146277893","title":"Polyrizon宣佈與Eurofins CDMO Amatsiaquitaine S.a.s合作生產cGMP臨床實驗材料，用於計劃中的美國臨床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1146277893","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146277893?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 19:55","pubTimestamp":1773143714,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. 已正式宣布，其将与Eurofins CDMO Amatsiaquitaine S.a.s合作，启动符合药品生产质量管理规范（GMP）的临床实验材料（CTM）生产工作。此项生产旨在为该公司计划在美国开展的临床研究提供所需材料。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121429365","title":"Polyrizon宣佈其納洛酮製劑研究取得積極成果，鼻腔沉積特性優於市售參照產品","url":"https://stock-news.laohu8.com/highlight/detail?id=1121429365","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121429365?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 21:14","pubTimestamp":1772111644,"startTime":"0","endTime":"0","summary":"生物制药公司Polyrizon Ltd.近日公布了一项关于其自主研发的纳洛酮鼻喷雾制剂的实验研究结果。研究数据显示，该公司的创新配方在关键的鼻腔沉积性能方面表现出显著优势，其沉积效果明显优于目前市面上的主流参照产品。\n这一积极成果标志着Polyrizon在药物递送技术领域取得了重要进展，为其纳洛酮产品的后续开发奠定了坚实基础。纳洛酮作为一种用于逆转阿片类药物过量的重要抢救药物，其鼻腔给药形式的有效性至关重要。此次研究的成功，预示着该配方有望为紧急用药场景提供更高效、更可靠的解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}]}}